Logo image of AMBI

AMBIPAR EMERGENCY RESPONSE (AMBI) Stock Fundamental Analysis

USA - NYSE Arca - NYSEARCA:AMBI - KYG025321020 - Common Stock

0.5396 USD
-0.06 (-10.31%)
Last: 10/28/2025, 8:04:02 PM
Fundamental Rating

3

Taking everything into account, AMBI scores 3 out of 10 in our fundamental rating. AMBI was compared to 82 industry peers in the Commercial Services & Supplies industry. Both the profitability and financial health of AMBI have multiple concerns. While showing a medium growth rate, AMBI is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year AMBI has reported negative net income.
AMBI had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: AMBI reported negative net income in multiple years.
Of the past 5 years AMBI 4 years had a positive operating cash flow.
AMBI Yearly Net Income VS EBIT VS OCF VS FCFAMBI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M

1.2 Ratios

The Return On Assets of AMBI (-0.35%) is comparable to the rest of the industry.
AMBI's Return On Equity of -1.42% is in line compared to the rest of the industry. AMBI outperforms 43.37% of its industry peers.
Looking at the Return On Invested Capital, with a value of 7.64%, AMBI is in the better half of the industry, outperforming 71.08% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for AMBI is in line with the industry average of 10.13%.
Industry RankSector Rank
ROA -0.35%
ROE -1.42%
ROIC 7.64%
ROA(3y)0.97%
ROA(5y)1.73%
ROE(3y)12.32%
ROE(5y)14.66%
ROIC(3y)8.34%
ROIC(5y)N/A
AMBI Yearly ROA, ROE, ROICAMBI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 10 20 30 40

1.3 Margins

Looking at the Operating Margin, with a value of 14.95%, AMBI belongs to the top of the industry, outperforming 85.54% of the companies in the same industry.
In the last couple of years the Operating Margin of AMBI has declined.
With a Gross Margin value of 14.74%, AMBI is not doing good in the industry: 81.93% of the companies in the same industry are doing better.
AMBI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 14.95%
PM (TTM) N/A
GM 14.74%
OM growth 3Y-11.61%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.87%
GM growth 5YN/A
AMBI Yearly Profit, Operating, Gross MarginsAMBI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 5 10 15 20

3

2. Health

2.1 Basic Checks

AMBI has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for AMBI remains at a similar level compared to 1 year ago.
The debt/assets ratio for AMBI is higher compared to a year ago.
AMBI Yearly Shares OutstandingAMBI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
AMBI Yearly Total Debt VS Total AssetsAMBI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

AMBI has an Altman-Z score of 1.00. This is a bad value and indicates that AMBI is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of AMBI (1.00) is worse than 66.27% of its industry peers.
AMBI has a debt to FCF ratio of 10.73. This is a negative value and a sign of low solvency as AMBI would need 10.73 years to pay back of all of its debts.
AMBI has a Debt to FCF ratio (10.73) which is in line with its industry peers.
AMBI has a Debt/Equity ratio of 2.00. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 2.00, AMBI is doing worse than 79.52% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2
Debt/FCF 10.73
Altman-Z 1
ROIC/WACC1.58
WACC4.83%
AMBI Yearly LT Debt VS Equity VS FCFAMBI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

AMBI has a Current Ratio of 1.79. This is a normal value and indicates that AMBI is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.79, AMBI is in the better half of the industry, outperforming 66.27% of the companies in the same industry.
AMBI has a Quick Ratio of 1.74. This is a normal value and indicates that AMBI is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.74, AMBI is doing good in the industry, outperforming 74.70% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.79
Quick Ratio 1.74
AMBI Yearly Current Assets VS Current LiabilitesAMBI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

AMBI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 67.09%, which is quite impressive.
The Revenue has grown by 25.42% in the past year. This is a very strong growth!
AMBI shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 58.09% yearly.
EPS 1Y (TTM)67.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-226.99%
Revenue 1Y (TTM)25.42%
Revenue growth 3Y58.09%
Revenue growth 5YN/A
Sales Q2Q%10.36%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AMBI Yearly Revenue VS EstimatesAMBI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 1B 2B 3B

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AMBI. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AMBI Price Earnings VS Forward Price EarningsAMBI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

96.39% of the companies in the same industry are more expensive than AMBI, based on the Enterprise Value to EBITDA ratio.
98.80% of the companies in the same industry are more expensive than AMBI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 0.56
EV/EBITDA 3.31
AMBI Per share dataAMBI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for AMBI!.
Industry RankSector Rank
Dividend Yield N/A

AMBIPAR EMERGENCY RESPONSE

NYSEARCA:AMBI (10/28/2025, 8:04:02 PM)

0.5396

-0.06 (-10.31%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners6.53%
Inst Owner Change-77.96%
Ins Owners1.68%
Ins Owner ChangeN/A
Market Cap29.91M
Revenue(TTM)3.25B
Net Income(TTM)-20.56M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.05
P/FCF 0.56
P/OCF 0.38
P/B 0.11
P/tB N/A
EV/EBITDA 3.31
EPS(TTM)-0.07
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.96
FCFY178.67%
OCF(TTM)1.42
OCFY262.66%
SpS10.93
BVpS4.88
TBVpS-2.67
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.35%
ROE -1.42%
ROCE 10.07%
ROIC 7.64%
ROICexc 8.23%
ROICexgc 15.86%
OM 14.95%
PM (TTM) N/A
GM 14.74%
FCFM 8.82%
ROA(3y)0.97%
ROA(5y)1.73%
ROE(3y)12.32%
ROE(5y)14.66%
ROIC(3y)8.34%
ROIC(5y)N/A
ROICexc(3y)8.89%
ROICexc(5y)N/A
ROICexgc(3y)20.26%
ROICexgc(5y)N/A
ROCE(3y)10.88%
ROCE(5y)N/A
ROICexgc growth 3Y-14.73%
ROICexgc growth 5YN/A
ROICexc growth 3Y-12.49%
ROICexc growth 5YN/A
OM growth 3Y-11.61%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.87%
GM growth 5YN/A
F-Score3
Asset Turnover0.56
Health
Industry RankSector Rank
Debt/Equity 2
Debt/FCF 10.73
Debt/EBITDA 3.58
Cap/Depr 41.78%
Cap/Sales 4.15%
Interest Coverage 3.35
Cash Conversion 52.13%
Profit Quality N/A
Current Ratio 1.79
Quick Ratio 1.74
Altman-Z 1
F-Score3
WACC4.83%
ROIC/WACC1.58
Cap/Depr(3y)86.46%
Cap/Depr(5y)N/A
Cap/Sales(3y)6.37%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)67.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-226.99%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)25.42%
Revenue growth 3Y58.09%
Revenue growth 5YN/A
Sales Q2Q%10.36%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y34.79%
EBIT growth 3Y39.74%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y277.14%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y436.92%
OCF growth 3Y87.11%
OCF growth 5YN/A

AMBIPAR EMERGENCY RESPONSE / AMBI FAQ

What is the ChartMill fundamental rating of AMBIPAR EMERGENCY RESPONSE (AMBI) stock?

ChartMill assigns a fundamental rating of 3 / 10 to AMBI.


What is the valuation status of AMBIPAR EMERGENCY RESPONSE (AMBI) stock?

ChartMill assigns a valuation rating of 2 / 10 to AMBIPAR EMERGENCY RESPONSE (AMBI). This can be considered as Overvalued.


What is the profitability of AMBI stock?

AMBIPAR EMERGENCY RESPONSE (AMBI) has a profitability rating of 3 / 10.